Comparison of Atorvastatin 5 and 20 mg/d for Reducing F-18 Fluorodeoxyglucose Uptake in Atherosclerotic Plaques on Positron Emission Tomography/Computed Tomography: A Randomized, Investigator-Blinded, Open-Label, 6-Month Study in Japanese Adults Scheduled for Percutaneous Coronary Intervention

Publication | Closed Access

Comparison of Atorvastatin 5 and 20 mg/d for Reducing F-18 Fluorodeoxyglucose Uptake in Atherosclerotic Plaques on Positron Emission Tomography/Computed Tomography: A Randomized, Investigator-Blinded, Open-Label, 6-Month Study in Japanese Adults Scheduled for Percutaneous Coronary Intervention

DOI

Citations

References

2010

Year

Hideki Ishii, Masami Nishio, Hiroshi Takahashi, Toru Aoyama, Miho Tanaka, Takanobu Toriyama, Tsuneo Tamaki, Daiji Yoshikawa, Mutsuharu Hayashi, Tetsuya Amano,

Clinical Therapeutics

Atorvastatin 5Percutaneous Coronary InterventionVascular DiseaseCardiovascular DiseaseAtherosclerosisMedicineMyocardial InfarctionJapanese Adults ScheduledPublic HealthPharmacologyCardiologyNuclear MedicineCoronary Artery DiseaseRadiologyCardiovascular Imaging